Home › Funds › Two Sigma Investments › MXCT
Two Sigma Investments position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2026)1.46M sh
Reported value held$1.80M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 11.64K | $142.00K | New |
| Q4 2021 | 22.30K | $227.00K | Add |
| Q1 2022 | 29.70K | $208.00K | Add |
| Q2 2022 | 56.29K | $266.00K | Add |
| Q2 2023 | 15.66K | $71.88K | New |
| Q4 2023 | 152.36K | $716.09K | New |
| Q1 2024 | 86.35K | $361.81K | Reduce |
| Q2 2024 | 23.41K | $91.75K | Reduce |
| Q4 2025 | 87.92K | $136.27K | New |
| Q1 2026 | 608.16K | $427.23K | Add |
| Q2 2026 | 1.46M | $1.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Citadel Advisors 955.72K sh · $1.18M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026